Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Irving

Showing results (31-40 of 194) with videos related to

Pageof 20
Sort By:
Current Gastroenterology Reports|November 12, 2009
Optimizing conventional therapies for inflammatory bowel diseaseMiles P Sparrow, Peter M Irving, Stephen B Hanauer
Journal of Crohn'S & Colitis|June 8, 2013
Alopecia areata: a possible extraintestinal manifestation of Crohn's diseaseKamal V Patel, Jeremy D Sanderson, Peter M Irving
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2005
Thrombosis and inflammatory bowel diseasePeter M Irving, K John Pasi, David S Rampton
Journal of Crohn'S & Colitis|November 26, 2013
Oesophageal Crohn's disease: a novel approach to managing iatrogenic perforation of an oesophageal Crohn's strictureKamal V Patel, Peter M Irving, Jeremy D Sanderson
Frontiers in Medicine|December 19, 2019
Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?Raphael P Luber, Sailish Honap, Georgina Cunningham, et al.
European Journal of Gastroenterology & Hepatology|August 19, 2004
Percutaneous endoscopic gastrostomy with a jejunal port for severe hyperemesis gravidarumPeter M Irving, Richard J S Howell, Ray G Shidrawi
Frontline Gastroenterology|April 11, 2022
Striking the balance with intravenous iron: too much or never enough?Raphael Luber, Esha Sharma, Peter M Irving, et al.
European Journal of Gastroenterology & Hepatology|June 1, 2012
Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysisLennard Y W Lee, Jeremy D Sanderson, Peter M Irving
Expert Opinion on Biological Therapy|October 20, 2018
Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?Mark A Samaan, Zehra Arkir, Tariq Ahmad, et al.
Current Opinion in Gastroenterology|April 26, 2019
Positioning biologics and new therapies in the management of inflammatory bowel diseaseSailish Honap, Georgina Cunningham, Aravind Gokul Tamilarasan, et al.
Pageof 20

Showing results (31-40 of 194) with videos related to

Sort By:
Pageof 20
Current Gastroenterology Reports|November 12, 2009
Optimizing conventional therapies for inflammatory bowel diseaseMiles P Sparrow, Peter M Irving, Stephen B Hanauer
Journal of Crohn'S & Colitis|June 8, 2013
Alopecia areata: a possible extraintestinal manifestation of Crohn's diseaseKamal V Patel, Jeremy D Sanderson, Peter M Irving
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2005
Thrombosis and inflammatory bowel diseasePeter M Irving, K John Pasi, David S Rampton
Journal of Crohn'S & Colitis|November 26, 2013
Oesophageal Crohn's disease: a novel approach to managing iatrogenic perforation of an oesophageal Crohn's strictureKamal V Patel, Peter M Irving, Jeremy D Sanderson
Frontiers in Medicine|December 19, 2019
Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?Raphael P Luber, Sailish Honap, Georgina Cunningham, et al.
European Journal of Gastroenterology & Hepatology|August 19, 2004
Percutaneous endoscopic gastrostomy with a jejunal port for severe hyperemesis gravidarumPeter M Irving, Richard J S Howell, Ray G Shidrawi
Frontline Gastroenterology|April 11, 2022
Striking the balance with intravenous iron: too much or never enough?Raphael Luber, Esha Sharma, Peter M Irving, et al.
European Journal of Gastroenterology & Hepatology|June 1, 2012
Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysisLennard Y W Lee, Jeremy D Sanderson, Peter M Irving
Expert Opinion on Biological Therapy|October 20, 2018
Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?Mark A Samaan, Zehra Arkir, Tariq Ahmad, et al.
Current Opinion in Gastroenterology|April 26, 2019
Positioning biologics and new therapies in the management of inflammatory bowel diseaseSailish Honap, Georgina Cunningham, Aravind Gokul Tamilarasan, et al.
Pageof 20